Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
1.
J Drugs Dermatol ; 20(5): 552-554, 2021 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-33938701

RESUMEN

Locally-advanced periocular basal cell carcinoma (BCC) pose many therapeutic challenges due to the need to preserve functionality and cosmesis of the orbit and periocular area. Surgical excision and subsequent orbital exenteration are two recognized modalities of treatment. Vismodegib is currently an FDA-approved monotherapy for locally-advanced and metastatic BCC. We present a case of the use of vismodegib as neoadjuvant therapy prior to surgical excision of a locally-advanced periocular recurrent BCC in a 75-year-old male. The patient’s tumor successfully responded to vismodegib allowing surgical excision with clear margins. The orbit was saved in a patient who otherwise would have required complete orbital exenteration. J Drugs Dermatol. 20(5):552-554. doi:10.36849/JDD.5661.


Asunto(s)
Anilidas/administración & dosificación , Carcinoma Basocelular/terapia , Neoplasias de los Párpados/terapia , Recurrencia Local de Neoplasia/terapia , Piridinas/administración & dosificación , Neoplasias Cutáneas/terapia , Administración Oral , Anciano , Anilidas/efectos adversos , Carcinoma Basocelular/diagnóstico , Carcinoma Basocelular/patología , Neoplasias de los Párpados/diagnóstico , Neoplasias de los Párpados/patología , Párpados/diagnóstico por imagen , Párpados/patología , Párpados/cirugía , Humanos , Imagen por Resonancia Magnética , Masculino , Márgenes de Escisión , Terapia Neoadyuvante/métodos , Recurrencia Local de Neoplasia/diagnóstico , Recurrencia Local de Neoplasia/patología , Tratamientos Conservadores del Órgano/métodos , Piridinas/efectos adversos , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/patología , Resultado del Tratamiento
2.
Australas J Dermatol ; 62(1): 64-68, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-33040339

RESUMEN

BACKGROUND: Actinic Keratosis is an intraepidermal neoplasm that represents the second most common reason for dermatologic visits in the United States. Sustained clearance with existing therapies is highly variable. OBJECTIVE: To assess the effects of combination and monotherapy with photodynamic therapy (PDT), grenz ray therapy, and PDT with microneedling (microchannel skin system) for actinic damage of the dorsal forearms and hands. METHODS: Full ethics approval was obtained through a Human Subjects Committee. Four patients with diffuse actinic field damage on their forearms and hands were recruited for the study. The dorsal forearm and hand from the elbow to the metacarpophalangeal joint were divided into four equal sections. Section 1 was treated with PDT. Section 2 was treated with grenz ray. Section 3 was treated with PDT plus microneedling. Section 4 was treated with grenz ray and PDT with microneedling. Lesion counts were recorded with transparent grids, photographed and evaluated by the same investigator at baseline, 1, 2, 3 and 6 months. RESULTS: At month 6 post treatment, lesion counts, as a per cent reduction from baseline, were 91.7% in section 1 (PDT); 97.3% in section 2 (grenz ray); 92.9% in section 3 (PDT + microneedle); and 93.9% in section 4 (grenz ray + PDT + microneedle). CONCLUSION: The greatest reduction occurred in the grenz ray monotherapy section and the second greatest reduction in the grenz ray, PDT, microneedling section. Further research on the efficacy of grenz ray therapy for field treatment of actinic keratosis of the forearms and hands is needed.


Asunto(s)
Queratosis Actínica/terapia , Fotoquimioterapia , Terapia por Rayos X , Anciano , Anciano de 80 o más Años , Punción Seca , Femenino , Antebrazo , Humanos , Masculino , Persona de Mediana Edad
4.
J Drugs Dermatol ; 18(3): 307-310, 2019 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-31020825

RESUMEN

Pyoderma gangrenosum (PG) is a destructive ulcerative process, which is usually idiopathic or associated with underlying systemic disease. Its pathogenesis remains unknown. A 30-year-old male with a history of Crohn's disease presented with an advanced perineal and inguinal ulcer consistent with pyoderma gangrenosum, which only partially responded to oral and intralesional corticosteroids and adalimumab 80mg biweekly. The patient was started on adjunct combination cyclosporine and thalidomide, which resulted in prompt relief and profound healing. Treatment of pyoderma gangrenosum is often challenging with no standardized treatment protocols. Combination therapy should be considered in patients with refractory disease, especially with failure of monotherapy. J Drugs Dermatol. 2019;18(3):307-310.


Asunto(s)
Enfermedad de Crohn/complicaciones , Ciclosporina/administración & dosificación , Inmunosupresores/administración & dosificación , Piodermia Gangrenosa/tratamiento farmacológico , Talidomida/administración & dosificación , Adalimumab/administración & dosificación , Corticoesteroides/administración & dosificación , Adulto , Antiinflamatorios/administración & dosificación , Diagnóstico Diferencial , Quimioterapia Combinada , Humanos , Masculino , Perineo , Piodermia Gangrenosa/diagnóstico , Piodermia Gangrenosa/patología
6.
Opt Express ; 27(3): 2867-2885, 2019 Feb 04.
Artículo en Inglés | MEDLINE | ID: mdl-30732318

RESUMEN

Polycrystalline ZnSe is an exciting source of broadband supercontinuum and high-harmonic generation via random quasi phase matching, exhibiting broad transparency in the mid-infrared (0.5-20 µm). In this work, the effects of wavelength, pulse power, intensity, propagation length, and crystallinity on supercontinuum and high harmonic generation are investigated experimentally using ultrafast mid-infrared pulses. Observed harmonic conversion efficiency scales linearly in propagation length, reaching as high as 36%. For the first time to our knowledge, n2 is measured for mid-infrared wavelengths in ZnSe: n2(λ=3.9 µm)=(1.2±0.3)×10-14 cm2/W. Measured n2 is applied to simulations modeling high-harmonic generation in polycrystalline ZnSe as an effective medium.

7.
8.
J Drugs Dermatol ; 16(12): 1305-1306, 2017 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-29240869

RESUMEN

Recalcitrant cutaneous sarcoidosis with perianal involvement is rare. To our knowledge we present the first documented case of cutaneous sarcoidosis with perianal involvement successfully treated with adalimumab.

J Drugs Dermatol. 2017;16(12):1305-1306.

.


Asunto(s)
Adalimumab/uso terapéutico , Anticuerpos Monoclonales Humanizados/uso terapéutico , Sarcoidosis/diagnóstico , Adalimumab/administración & dosificación , Canal Anal/patología , Anticuerpos Monoclonales Humanizados/administración & dosificación , Diagnóstico Diferencial , Humanos , Inyecciones Subcutáneas , Masculino , Persona de Mediana Edad , Sarcoidosis/tratamiento farmacológico , Sarcoidosis/patología , Resultado del Tratamiento
12.
Dermatol Clin ; 34(3): 319-33, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27363889

RESUMEN

Guidelines for appropriate use of superficial radiation therapy are based on decades of research; although no formal appropriate use criteria have been developed, they are warranted. Superficial radiation in the outpatient dermatologic setting is the least expensive form of radiation treatment. Although higher cure rates may be possible with Mohs surgery, this should never argue against dermatologists retaining and refining a modality, nor should we limit its use by our successors. Most important, our elderly and infirm patients should continue to benefit from superficial radiation therapy in outpatient dermatologic settings.


Asunto(s)
Carcinoma Basocelular/radioterapia , Carcinoma de Células Escamosas/radioterapia , Dermatología/educación , Pautas de la Práctica en Medicina , Neoplasias Cutáneas/radioterapia , Atención Ambulatoria , Carcinoma Basocelular/patología , Carcinoma de Células Escamosas/patología , Contraindicaciones , Curriculum , Medicina Basada en la Evidencia , Humanos , Internado y Residencia , Guías de Práctica Clínica como Asunto , Radioterapia/economía , Radioterapia/estadística & datos numéricos , Ensayos Clínicos Controlados Aleatorios como Asunto , Neoplasias Cutáneas/patología , Terminología como Asunto
15.
Australas J Dermatol ; 57(2): e66-8, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26299801

RESUMEN

Agent Blue was an arsenical herbicide used extensively in the Vietnam War. Arsenic is one of the known causes of acquired palmoplantar keratoderma (PPK). The most common manifestation of arsenic exposure in susceptible individuals is bilateral palmoplantar hyperkeratosis. We report a 67-year-old man with no known prior exposure to arsenic in the USA or family history of PPK who developed multiple squamous cell carcinoma in situ (SCCIS) and palmoplantar hyperkeratotic lesions beginning 23 years after service in Vietnam. The SCCIS were located on the trunk and extremities in both sun-exposed and non-sun-exposed sites and his palmoplantar lesions were diagnosed concurrently with his SCCIS. He has continued to develop SCCIS since his first visit to our clinic 25 years ago.


Asunto(s)
Enfermedad de Bowen/inducido químicamente , Herbicidas/toxicidad , Queratodermia Palmoplantar/inducido químicamente , Neoplasias Cutáneas/inducido químicamente , Anciano , Humanos , Masculino , Veteranos , Guerra de Vietnam
18.
Australas J Dermatol ; 54(1): 64-8, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22780558

RESUMEN

Multiple basal cell carcinomas (BCC) are a significant cause of morbidity and disfigurement in patients with naevoid basal cell carcinoma syndrome (NBCCS). Chemopreventive strategies are needed to reduce the formation of new BCC in these patients. Appropriate evidence-based guidelines for photodynamic therapy chemoprevention in NBCCS do not exist. We herein report one patient treated with methyl aminolevulinate PDT with red light (630 nm) activation to continue sustained chemoprevention following other BCC chemopreventive modalities and a relevant literature review.


Asunto(s)
Síndrome del Nevo Basocelular/prevención & control , Carcinoma Basocelular/prevención & control , Neoplasias Faciales/prevención & control , Fotoquimioterapia , Neoplasias Cutáneas/prevención & control , Síndrome del Nevo Basocelular/patología , Carcinoma Basocelular/patología , Neoplasias Faciales/patología , Femenino , Humanos , Persona de Mediana Edad , Neoplasias Cutáneas/patología
20.
J Drugs Dermatol ; 11(11): 1364-5, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23135091

RESUMEN

Methyl aminolevulinate photodynamic therapy (MAL-PDT) is utilized in several countries for the treatment of basal cell carcinoma, but allergic sensitization has been reported by the manufacturer. To the best of our knowledge, we report the first case of urticaria following MAL-PDT in a patient with nevoid basal cell carcinoma syndrome. Prophylactic use of antihistamines may allow continued use of MAL-PDT in this setting.


Asunto(s)
Ácido Aminolevulínico/análogos & derivados , Fotoquimioterapia/efectos adversos , Fármacos Fotosensibilizantes/efectos adversos , Urticaria/etiología , Ácido Aminolevulínico/efectos adversos , Ácido Aminolevulínico/uso terapéutico , Síndrome del Nevo Basocelular/tratamiento farmacológico , Síndrome del Nevo Basocelular/patología , Carcinoma Basocelular/tratamiento farmacológico , Carcinoma Basocelular/patología , Femenino , Humanos , Persona de Mediana Edad , Fotoquimioterapia/métodos , Fármacos Fotosensibilizantes/uso terapéutico , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA